The Nasdaq Stock Market said it plans to officially suspend KaloBios Pharmaceuticals on Wednesday, as the biotech firm remains under scrutiny since the arrest of former Chief Executive Martin Shkreli.
from WSJ.com: US Business http://ift.tt/1mUrZkI
via IFTTT
No comments:
Post a Comment